HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intralesional triamcinolone therapy for pretibial myxedema.

Abstract
In a prospective study, nine patients with pretibial myxedema were treated with intralesional injections of triamcinolone acetonide. Complete resolution of the myxedematous plaques was obtained in seven of the nine patients. The other two patients failed to complete their treatment programs but did show partial resolution. For most patients the monthly injection of 8 ml or less of a solution containing 5 mg/ml of triamcinolone proved to be the most effective dosage schedule. No serious side effects were encountered. New nodules of myxedema developed in some patients after the initial completion of therapy; these nodules responded to reinjection using the same dosage schedule.
AuthorsP G Lang, J C Sisson, P J Lynch
JournalArchives of dermatology (Arch Dermatol) Vol. 111 Issue 2 Pg. 197-202 (Feb 1975) ISSN: 0003-987X [Print] United States
PMID1115509 (Publication Type: Journal Article)
Chemical References
  • Triamcinolone Acetonide
Topics
  • Adult
  • Aged
  • Biopsy
  • Female
  • Humans
  • Injections, Subcutaneous
  • Male
  • Middle Aged
  • Myxedema (drug therapy, pathology)
  • Prospective Studies
  • Skin (pathology)
  • Tibia
  • Time Factors
  • Triamcinolone Acetonide (administration & dosage, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: